Skip to Content

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in News for Health Professionals

Parents Struggling to Provide for Families During Pandemic

The COVID-19 pandemic poses risks to children's health, well-being, and development as parents struggle to provide for their families, according to a survey released by the Urban Institute. The Urban Institute's Health Reform Monitoring Survey was conducted between March 25 and April 10, 2020. The analysis included responses from 9,032 adults (aged...

Posted today in Medical

Only Half of Americans Say They'd Get a Coronavirus Vaccine: Survey

Even if a vaccine against the new coronavirus is developed, only half of Americans say they'd get it, a new survey finds. It also found that 31% weren't sure if they'd get vaccinated, and about 1 in 5 said they wouldn't get vaccinated. Of those who'd refuse a vaccine, 7 in 10 cited safety concerns, according to the Associated Press-NORC Center for...

Posted today in Medical

Pollen Fragments Linger After Rains, Leaving Allergy Sufferers Miserable

Spring showers bring … pollen. That's the surprising discovery made by researchers when they measured tree pollen fragment concentrations during and after spring rains of varying intensity in Iowa City between April 17 and May 31, 2019. Rain fell on 28 days of the study period, which is prime tree pollen season. There were light rains, thunderstorms,...

Posted 2 days ago in New Drug Approvals

FDA Approves Dupixent (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis

TARRYTOWN, N.Y. and PARIS, May 26, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis whose disease is not adequately controlled...

Posted yesterday in New Drug Approvals

FDA Approves Artesunate for Injection for the Treatment of Severe Malaria

Amivas (US), LLC, specialists in treatments for rare and neglected tropical diseases, including severe malaria, announced today that Artesunate for Injection 110 mg, powder and solvent for solution has received marketing approval by the US Food and Drug Administration (FDA). Artesunate for Injection is indicated for the initial treatment of severe malaria...

Posted 3 days ago in Clinical Trials

Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine

 Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX‑CoV2373, a stable, prefusion protein made using its proprietary nanoparticle technology....

Posted today in Medical

'Silent' COVID-19 More Widespread Than Thought

A new cruise ship study suggests that the number of people who are infected with the new coronavirus but have no symptoms may be much higher than believed. More than 80% of those who tested positive for the infection had no symptoms, according to the study published online May 27 in the journal Thorax. The findings could be important as lockdown restrictions...

Posted today in Medical

As a Nation's Worth Grows, So Do Waistlines

Fatter wallets lead to fatter people, according to a new study. Researchers examined the link between nations' wealth and their obesity rates. They discovered citizens get plumper as their country gets richer. "As most people currently live in low- and middle-income countries with rising incomes, our findings underscore the urgent need for effective...

Posted today in Medical

Vaping Could Put You at Risk for Gum Disease

E-cigarettes can damage more than your lungs: New research shows that only a few months of vaping might also trigger gum disease. "Vaping is such a big assault on the oral environment, and the change happens dramatically and over a short period of time," said study senior author Dr. Purnima Kumar, a professor of periodontology at Ohio State University. She...

Posted today in Medical

FDA Approves IV Artesunate for Severe Malaria

Intravenous (IV) artesunate received approval from the U.S. Food and Drug Administration to treat adults and children with severe malaria, the agency announced Tuesday. This approval marks the first for severe malaria since the marketing of quinine was discontinued in early 2019. Before the current approval, U.S. patients with severe malaria and those...

Read more news...

Recently added consumer and prescribing information: Qinlock, Retevmo, Tabrecta, Ongentys, Trodelvy, Tukysa, Koselugo, Nexlizet, Nurtec ODT, Isturisa

Posted in Blog

Vitamin C: Time to take this supplement seriously?

Vitamin C has always been a controversial supplement. To some, it belongs firmly in the alternative medicine basket, with apparently no substantial evidence to support its use. To others, it holds promise, particularly if you are talking about certain groups of people who are likely to be low in vitamin C. Because we NEED vitamin […]

Posted in Blog

Medical Advances Amidst COVID-19 Chaos

Undeniably, we are in unprecedented times. COVID-19 is a serious and fatal disease for some and globally it has, and will continue to have, wide-reaching implications, medically, socially, and financially for some time. But medical advances will be significant. Although we have learned a lot about the new coronavirus already, there is still a lot […]

Posted in Blog

Coronavirus – When Do We Hit Red for Panic?

On December the 31st, 2019, China alerted the World Health Organization (WHO) to a cluster of cases of unusual pneumonia. Several of those infected had worked at the Huanan Seafood Wholesale Market in Wuhan and early reports suggested 40 people had the new illness. By the 7th of January, the virus had been identified as […]

See more blog posts or follow us on twitter.